Reports for MINT PHARMACEUTICALS INC

Company Name

MINT PHARMACEUTICALS INC

Totals

Shortage reports

132

Actual shortage: 30 (23%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 102 (77%)

Discontinuation Reports

29

To be discontinued: 0 (0%)
Discontinued: 29 (100%)
Reversed: 0 (0%)

Late reports

33 (20%)

Overdue reports

7 (23%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MINT-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-19 2024-03-19 222750
MINT-ATORVASTATIN 40MG TABLET Resolved 2024-01-29 2024-01-30 217696
MINT-ATORVASTATIN 20MG TABLET Resolved 2024-01-29 2024-01-30 217693
MINT-ATORVASTATIN 10MG TABLET Resolved 2024-01-29 2024-01-30 217690
MINT-TOPIRAMATE 200MG TABLET Actual shortage 2024-01-29 2024-01-29 217687
MINT-TOPIRAMATE 100MG TABLET Actual shortage 2024-01-29 2024-01-29 217684
MINT-TOPIRAMATE 25MG TABLET Resolved 2024-01-29 2024-03-26 217681
MINT-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-26 2024-01-26 217396
MINT-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-26 2024-03-26 217393
MINT-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-26 2024-03-26 217390
MINT-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-26 2024-01-26 217387
MINT-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-26 2024-01-26 217384
MINT-PRAVASTATIN 40MG TABLET TABLET Resolved 2024-01-26 2024-03-26 217381
MINT-PRAVASTATIN 20MG TABLET TABLET Actual shortage 2024-01-26 2024-03-25 217378
MINT-PRAVASTATIN 10MG TABLET TABLET Resolved 2024-01-26 2024-03-26 217375
MINT-LETROZOLE 2.5MG TABLET Actual shortage 2024-01-26 2024-01-26 217372
MINT-ANASTROZOLE 1MG TABLET Resolved 2024-01-26 2024-03-26 217369
MINT-ALENDRONATE 70.0MG TABLET Actual shortage 2024-01-26 2024-01-26 217366
MINT-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-07-24 2024-01-09 199939
MINT-DICLOFENAC 0.1% SOLUTION Actual shortage 2023-03-27 2023-09-27 188045

Showing 1 to 20 of 132

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MINT-CITALOPRAM 40MG TABLET Discontinued 2023-05-02 2023-05-03 191442
MINT-CITALOPRAM 20MG TABLET Discontinued 2023-05-02 2023-05-03 191439
MINT-LEVOFLOXACIN 750MG TABLET Discontinued 2022-10-02 2022-10-03 170859
MINT-LEVOFLOXACIN 500MG TABLET Discontinued 2022-10-02 2022-10-03 170856
MINT-LEVOFLOXACIN 250MG TABLET Discontinued 2022-10-02 2022-10-03 170853
MINT-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2021-08-11 2021-08-11 143959
MINT-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2021-08-11 2021-08-11 143956
MINT-IRBESARTAN/HCTZ 12.5MG 300MG TABLET Discontinued 2021-08-11 2021-08-11 143952
MINT-FENOFIBRATE E 145MG TABLET Discontinued 2020-04-25 2020-04-25 113175
MINT-METFORMIN 850MG TABLET Discontinued 2020-03-09 2020-03-10 108292
MINT-SOLIFENACIN 10MG TABLET Discontinued 2019-10-09 2019-10-10 95916
MINT-SOLIFENACIN 5MG TABLET Discontinued 2019-10-09 2019-10-10 95913
MINT-ROSUVASTATIN 40MG TABLET Discontinued 2019-10-09 2019-10-10 95907
MINT-ROSUVASTATIN 20MG TABLET Discontinued 2019-10-09 2019-10-10 95903
MINT-ROSUVASTATIN 10MG TABLET Discontinued 2019-10-09 2019-10-10 95900
MINT-ROSUVASTATIN 5MG TABLET Discontinued 2019-10-09 2019-10-10 95897
MINT-METFORMIN 500MG TABLET Discontinued 2019-07-04 2019-07-05 88513
MINT-DORZOLAMIDE/TIMOLOL 5MG 20MG SOLUTION Discontinued 2019-06-04 2019-06-04 85525
MINT-CLOPIDOGREL Discontinued 2019-02-04 2019-02-05 74442
MINT-CLOPIDOGREL Discontinued 2019-02-04 2019-02-05 74435

Showing 1 to 20 of 29